Neuro Serge Reviews (DOCTOR INVESTIGATES) Cognitive Support Benefits, Risks & Who Should Avoid It In 2026

January 24, 2026 11:20 AM

Cognitive decline, brain fog, and focus loss are no longer slow-burning problems, they're immediate performance blockers, and millions are feeling them daily. That urgency is exactly why Neuro Serge Reviews exploded going into 2026. Unlike outdated nootropics that require weeks of buildup, Neuro Serge is widely reported to deliver noticeable cognitive clarity, sharper focus, and mental energy within days, without stimulants, crashes, or side...

Read more

Ireland Acute Care EHR and Digital Health 2026 Report Released

January 24, 2026 10:30 AM

Black Book Market Research LLC Insights today announced the release of Ireland Acute Care EHR and Digital Health 2026, an Ireland-specific companion report built for executives, clinical informatics leaders, digital transformation teams, and technology suppliers navigating the country's next wave of acute-care EHR modernisation through 2026-2030.The report is available gratis to qualified global healthcare IT stakeholders seeking a...

Read more

Onco-Innovations Announces Private Placement

January 23, 2026 7:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") announces that it intends to complete a non-brokered private placement (the "Private Placement") of up to 2,272,727 units of the Company (the "Units") at a price of $0.88 per Unit, for aggregate gross proceeds of up to $2,000,000. Each Unit shall consist of one common share (each a "Share") and one-half of one common share purchase warrant...

Read more

Black Book Market Research Publishes Trust Framework to Advance Independent, KPI-Based Benchmarking in Healthcare Technology and Services

January 23, 2026 4:30 PM

Black Book Market Research today published the Black Book Trust Framework, a formal standard that defines how the firm designs research programs, benchmarks performance, and recognizes high-performing healthcare technology and services providers. Built for a rapidly globalizing health IT market, the framework is intended to support more defensible evaluation by applying measurable KPIs, published definitions, and continuous...

Read more

Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity

January 23, 2026 4:01 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company providing innovative point-of-care diagnostic and therapeutic solutions for equine and companion animals, today announced the integration of advanced artificial intelligence (AI) interpretation capabilities into its TRUVIEW® AI digital microscopy system.The AI enhancement expands functionality of the TRUVIEW system by enabling automated interpretation of...

Read more

Arialief Reviews (URGENT SAFETY REPORT) Real Results, Hidden Complaints & Side Effects In 2026

January 23, 2026 2:35 PM

Nerve discomfort is no longer a fringe health issue, it's a growing, everyday problem affecting millions of adults worldwide. Burning sensations, tingling in the feet, sharp nerve jolts, and unexplained numbness are now among the most searched health complaints heading into 2026. As frustration with prescriptions, injections, and temporary fixes grows, consumers are actively searching for safer, long-term solutions that support nerve health at...

Read more

Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds

January 23, 2026 2:10 PM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, announced today the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 13,065,000 shares of common stock, issued by the Company on September 11, 2025 (the "Existing Warrants"), at reduced exercise price of $0.86 per...

Read more

Mentavi Health Presented Validation Data for Its Online Adult ADHD Diagnostic Evaluation at APSARD 2026

January 23, 2026 9:50 AM

Mentavi Health, a telehealth leader in evidence-based digital mental health care, participated in the APSARD 2026 Annual Conference (American Professional Society for ADHD and Related Disorders), held January 15-18, 2026, in San Diego. Mentavi Chief Medical Officer Barry K. Herman, MD, MMM, presented a scientific poster summarizing Mentavi's peer-reviewed validation study of its online, asynchronous, clinician-reviewed diagnostic evaluation for...

Read more

Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit

January 23, 2026 9:00 AM

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and commercializing nucleic acid delivery technology for targets beyond the liver, announced today that it will be presenting at the 5th mRNA-Based Therapeutics Summit Europe, being held January 28-29, 2026, in Berlin. Covadonga Pañeda, Ph.D., Altamira Therapeutics' Chief Operating Officer, will give a presentation entitled "CycloPhore &...

Read more

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony

January 23, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, CEO Dr Raza Bokhari joined Steve Darling from Proactive https://youtu.be/8EErx6aQEXs to announce that the company was honored with the opportunity to ring the Nasdaq Opening Bell at the Nasdaq MarketSite in New York's Times...

Read more

Cantargia Reports First Patient Dosed in New US Investigator-Initiated Colorectal Cancer Study

January 23, 2026 1:50 AM

Cantargia AB (Publ) (STO:CANTA) today reported that the first patient has been dosed in a Phase 1b/2 clinical trial investigating nadunolimab in combination with checkpoint inhibitor therapy in up to 24 patients with chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC). The study is an investigator-led initiative in collaboration with Dr. Dan Fang at Tisch Cancer Institute, Icahn School of Medicine at Mount...

Read more

Monthly New Moon Circle Invites Community to Reset, Release, and Reimagine

January 22, 2026 5:20 PM

The Neurodivergent Empowerment Institute (NEI) will host its upcoming New Moon Circle Monthly, on the Sunday closest to the New Moon, offering a guided, trauma-informed community experience centered on the theme "Reset, Release, Reimagine."Rooted in NEI's mission to support emotional regulation, self-understanding, and inclusive community spaces, the New Moon Circle provides a structured pause point within the lunar cycle; an intentional moment...

Read more

BioResearch Partner(TM) Expands Into Georgia

January 22, 2026 5:10 PM

One of South Florida's most luminary clinical research site management organizations has expanded its clinical research footprint into the City of Atlanta, GA, strategically positioning BioResearch Partner™ across north, south, and east Atlanta, and extends access to diverse, high-growth communities and reinforcing BRP's role as a vanguard in national clinical site development. Building on its proven success in South Florida, BioResearch...

Read more

trusti and The PrEP Clinic Launch Ontario Pilot to Expand Free Rapid HIV Screening and Access to PrEP and HIV Care

January 22, 2026 10:35 AM

trusti, Canada's latest at-home rapid STI testing platform, has announced a new pilot partnership with The PrEP Clinic, Ontario's full-service HIV prevention and treatment provider. The collaboration makes trusti's rapid HIV test kits available at no cost through The PrEP Clinic as a preliminary screening tool, while establishing The PrEP Clinic as a referral partner for any trusti client across Ontario who requires confirmatory testing, HIV...

Read more

Diversatek Healthcare Announces the Launch of the EZ-Ject Injection Needle

January 22, 2026 10:00 AM

Diversatek Healthcare, a provider of gastrointestinal devices and diagnostic testing systems, has launched its EZ-Ject™ Injection Needle, expanding its proven line of high-performance therapeutic endoscopy devices. The EZ-Ject Injection Needle features a one-step locking mechanism that secures the needle in place with no twisting required. A Diversatek Healthcare customer described the locking mechanism as "simple and secure," highlighting...

Read more

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi

January 22, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today provided updates regarding the company's strategic focus on its rare disease development program for crofelemer, which is focused on near-term milestones for the treatment of intestinal failure in patients with short bowel syndrome (SBS-IF) and microvillus inclusion disease (MVID). The company has received Orphan Drug Designation for both diseases for crofelemer in the US and EU. This development effort is...

Read more

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity

January 22, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP), a leader in innovative patent-pending sublingual delivery technologies, today announced it has taken delivery of two million units of its flagship caffeine supplement, BUZZ BOMB™.This delivery marks a critical milestone in Aspire's commercialization strategy, introducing a comprehensive brand relaunch and redesigned packaging. The new aesthetic is engineered for high-impact shelf presence and...

Read more

vVARDIS Advances Sustainable, Drill-Free Caries Management Consistent With WHO's Forward-Looking Vision for Environmentally Friendly Oral Health

January 22, 2026 7:25 AM

vVARDIS, a Swiss high-growth healthcare company welcomes the release of the World Health Organisation's (WHO) Guideline on Environmentally Friendly and Less Invasive Oral Health Care for Preventing and Managing Dental Caries, a global crisis affecting an estimated 2.5 billion people worldwide, according to the WHO. This guideline supports the Bangkok Declaration and the transition to preventive, less invasive, climate resilient, environmentally...

Read more

Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

January 22, 2026 7:00 AM

Bristol Myers Squibb (NYSE:BMY, "BMS"), a global leader in oncology, announced an agreement with Microsoft, a market leader in AI-powered radiology and clinical workflow technologies, aiming to accelerate early detection of lung cancer.Through this digital health collaboration, U.S. FDA-cleared radiology AI algorithms will be deployed via Microsoft's Precision Imaging Network, part of Microsoft for Healthcare radiology solutions. Today, more...

Read more

Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health

January 22, 2026 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced that it has entered into a contract manufacturing and service agreement with Rahm Sensor Development, a technology company advancing contact-free, multi-sensor monitoring solutions for high-risk environments.Under the agreement, Zomedica will manufacture...

Read more